Form 8-K - Current report:
SEC Accession No. 0000950170-23-026747
Filing Date
2023-06-07
Accepted
2023-06-07 08:52:01
Documents
12
Period of Report
2023-06-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K fate-20230607.htm   iXBRL 8-K 56071
  Complete submission text file 0000950170-23-026747.txt   171024

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fate-20230607_lab.xml EX-101.LAB 12806
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fate-20230607_pre.xml EX-101.PRE 9469
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fate-20230607.xsd EX-101.SCH 2493
6 EXTRACTED XBRL INSTANCE DOCUMENT fate-20230607_htm.xml XML 4520
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 23997764
SIC: 2836 Biological Products, (No Diagnostic Substances)